sRANK-Fc (Amgen)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamesRANK-Fc (Amgen)
Drug Alias NamesRANK-Fc (Immunex)RANK-L antagonist (Amgen)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitors
TargetsTumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunex Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen IncImmunex Corp
Active IndicationsN/A
Inactive IndicationsBone Diseases

Other Information

ATC CodeN/A
Related LinksN/A